BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · IEX Real-Time Price · USD
1.365
-0.085 (-5.86%)
At close: May 3, 2024, 4:00 PM
1.350
-0.015 (-1.10%)
After-hours: May 3, 2024, 7:50 PM EDT

BioRestorative Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2009
Net Income
-14.42-18.49-44.3-11.27-14.65-12.52-9.44-8.64-7.92-5.59
Upgrade
Depreciation & Amortization
0.260.280.210.150.230.240.260.260.210.1
Upgrade
Share-Based Compensation
7.7812.6123.110.691.662.43.62.541.951.36
Upgrade
Other Operating Activities
-0.05-0.3117.668.465.844.771.730.842.630.9
Upgrade
Operating Cash Flow
-6.43-5.91-3.33-1.96-6.92-5.1-3.85-5-3.12-3.23
Upgrade
Capital Expenditures
-0.17-0.27-0.030-0.04-0.01-0-0.19-0.41-0.17
Upgrade
Change in Investments
3.42-12.9600000000
Upgrade
Other Investing Activities
--0.18-------0.08-
Upgrade
Investing Cash Flow
3.25-13.4-0.030-0.04-0.01-0-0.19-0.48-0.17
Upgrade
Share Issuance / Repurchase
2.35021.070.011.660.592.083.712.32.72
Upgrade
Debt Issued / Paid
000.255.525.184.232.21.051.770.57
Upgrade
Other Financing Activities
----0.5--0.04-0.29-0.39-
Upgrade
Financing Cash Flow
2.35021.325.036.844.784.285.063.683.29
Upgrade
Net Cash Flow
-0.83-19.3117.963.06-0.12-0.330.42-0.130.07-0.11
Upgrade
Free Cash Flow
-6.6-6.18-3.36-1.96-6.95-5.12-3.86-5.19-3.53-3.4
Upgrade
Free Cash Flow Margin
-4527.61%-5157.20%-7305.58%-2550.99%-5349.51%-4610.36%-4762.27%-14279.85%-561.31%-816.17%
Upgrade
Free Cash Flow Per Share
-1.56-1.71-2.83-4.98-1248.69-2.68-2845.56-5057.64-5710.14-10635.87
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).